You just read:

Pique Therapeutics Announces Positive Results in Phase 2 Clinical Trial of Lead Immunotherapy for Non-Small Cell Lung Cancer

News provided by

Pique Therapeutics, Inc.

Nov 07, 2017, 08:00 ET